Skip to main content
NCBI home page
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 1994 Mar;5(3):339–347. doi: 10.1091/mbc.5.3.339

Epidermal growth factor receptor-dependent stimulation of amphiregulin expression in androgen-stimulated human prostate cancer cells.

I Sehgal 1, J Bailey 1, K Hitzemann 1, M R Pittelkow 1, N J Maihle 1
PMCID: PMC301041  PMID: 8049525

Abstract

Amphiregulin is a heparin-binding epidermal growth factor (EGF)-related peptide that binds to the EGF receptor (EGF-R) with high affinity. In this study, we report a role for amphiregulin in androgen-stimulated regulation of prostate cancer cell growth. Androgen is known to enhance EGF-R expression in the androgen-sensitive LNCaP human prostate carcinoma cell line, and it has been suggested that androgenic stimuli may regulate proliferation, in part, through autocrine mechanisms involving the EGF-R. In this study, we demonstrate that LNCaP cells express amphiregulin mRNA and peptide and that this expression is elevated by androgenic stimulation. We also show that ligand-dependent EGF-R stimulation induces amphiregulin expression and that androgenic effects on amphiregulin synthesis are mediated through this EGF-R pathway. Parallel studies using the estrogen-responsive breast carcinoma cell line, MCF-7, suggest that regulation of amphiregulin by estrogen may also be mediated via an EGF-R pathway. In addition, heparin treatment of LNCaP cells inhibits androgen-stimulated cell growth further suggesting that amphiregulin can mediate androgen-stimulated LNCaP proliferation. Together, these results implicate an androgen-regulated autocrine loop composed of amphiregulin and its receptor in prostate cancer cell growth and suggest that the mechanism of steroid hormone regulation of amphiregulin synthesis may occur through androgen upregulation of the EGF-R and subsequent receptor-dependent pathways.

Full text

PDF
339

Images in this article

341Image
on p.341
342Image
on p.342
343Image
on p.343
344Image
on p.344
344Image
on p.344

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berns E. M., de Boer W., Mulder E. Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human prostate tumor cell line LNCaP. Prostate. 1986;9(3):247–259. doi: 10.1002/pros.2990090305. [DOI] [PubMed] [Google Scholar]
  2. Boring C. C., Squires T. S., Tong T. Cancer statistics, 1993. CA Cancer J Clin. 1993 Jan-Feb;43(1):7–26. doi: 10.3322/canjclin.43.1.7. [DOI] [PubMed] [Google Scholar]
  3. Connolly J. M., Rose D. P. Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate. 1990;16(3):209–218. doi: 10.1002/pros.2990160304. [DOI] [PubMed] [Google Scholar]
  4. Connolly J. M., Rose D. P. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate. 1989;15(2):177–186. doi: 10.1002/pros.2990150211. [DOI] [PubMed] [Google Scholar]
  5. Cook P. W., Mattox P. A., Keeble W. W., Pittelkow M. R., Plowman G. D., Shoyab M., Adelman J. P., Shipley G. D. A heparin sulfate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol Cell Biol. 1991 May;11(5):2547–2557. doi: 10.1128/mcb.11.5.2547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dickson R. B., Huff K. K., Spencer E. M., Lippman M. E. Induction of epidermal growth factor-related polypeptides by 17 beta-estradiol in MCF-7 human breast cancer cells. Endocrinology. 1986 Jan;118(1):138–142. doi: 10.1210/endo-118-1-138. [DOI] [PubMed] [Google Scholar]
  7. Gabelman B. M., Emerman J. T. Effects of estrogen, epidermal growth factor, and transforming growth factor-alpha on the growth of human breast epithelial cells in primary culture. Exp Cell Res. 1992 Jul;201(1):113–118. doi: 10.1016/0014-4827(92)90354-b. [DOI] [PubMed] [Google Scholar]
  8. Gibbons R. P. Prostate cancer. Chemotherapy. Cancer. 1987 Aug 1;60(3 Suppl):586–588. doi: 10.1002/1097-0142(19870801)60:3+<586::aid-cncr2820601525>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  9. Gill G. N., Kawamoto T., Cochet C., Le A., Sato J. D., Masui H., McLeod C., Mendelsohn J. Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity. J Biol Chem. 1984 Jun 25;259(12):7755–7760. [PubMed] [Google Scholar]
  10. Henttu P., Vihko P. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP. Cancer Res. 1993 Mar 1;53(5):1051–1058. [PubMed] [Google Scholar]
  11. Hofer D. R., Sherwood E. R., Bromberg W. D., Mendelsohn J., Lee C., Kozlowski J. M. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha. Cancer Res. 1991 Jun 1;51(11):2780–2785. [PubMed] [Google Scholar]
  12. Horoszewicz J. S., Leong S. S., Kawinski E., Karr J. P., Rosenthal H., Chu T. M., Mirand E. A., Murphy G. P. LNCaP model of human prostatic carcinoma. Cancer Res. 1983 Apr;43(4):1809–1818. [PubMed] [Google Scholar]
  13. Ibrahim G. K., Kerns B. J., MacDonald J. A., Ibrahim S. N., Kinney R. B., Humphrey P. A., Robertson C. N. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol. 1993 Jan;149(1):170–173. doi: 10.1016/s0022-5347(17)36032-9. [DOI] [PubMed] [Google Scholar]
  14. Johnson G. R., Saeki T., Auersperg N., Gordon A. W., Shoyab M., Salomon D. S., Stromberg K. Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem Biophys Res Commun. 1991 Oct 31;180(2):481–488. doi: 10.1016/s0006-291x(05)81090-3. [DOI] [PubMed] [Google Scholar]
  15. Karnes W. E., Jr, Walsh J. H., Wu S. V., Kim R. S., Martin M. G., Wong H. C., Mendelsohn J., Park J. G., Cuttitta F. Autonomous proliferation of colon cancer cells that coexpress transforming growth factor alpha and its receptor. Variable effects of receptor-blocking antibody. Gastroenterology. 1992 Feb;102(2):474–485. doi: 10.1016/0016-5085(92)90093-e. [DOI] [PubMed] [Google Scholar]
  16. Knabbe C., Kellner U., Schmahl M., Voigt K. D. Growth factors in human prostate cancer cells: implications for an improved treatment of prostate cancer. J Steroid Biochem Mol Biol. 1991;40(1-3):185–192. doi: 10.1016/0960-0760(91)90181-4. [DOI] [PubMed] [Google Scholar]
  17. Li S., Plowman G. D., Buckley S. D., Shipley G. D. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J Cell Physiol. 1992 Oct;153(1):103–111. doi: 10.1002/jcp.1041530114. [DOI] [PubMed] [Google Scholar]
  18. Mansson P. E., Adams P., Kan M., McKeehan W. L. Heparin-binding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res. 1989 May 1;49(9):2485–2494. [PubMed] [Google Scholar]
  19. Matuo Y., Nishi N., Matsui S., Sandberg A. A., Isaacs J. T., Wada F. Heparin binding affinity of rat prostatic growth factor in normal and cancerous prostates: partial purification and characterization of rat prostatic growth factor in the Dunning tumor. Cancer Res. 1987 Jan 1;47(1):188–192. [PubMed] [Google Scholar]
  20. McKeehan W. L., Adams P. S., Rosser M. P. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res. 1984 May;44(5):1998–2010. [PubMed] [Google Scholar]
  21. Page M. J., Field J. K., Everett N. P., Green C. D. Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. Cancer Res. 1983 Mar;43(3):1244–1250. [PubMed] [Google Scholar]
  22. Pietrzkowski Z., Mulholland G., Gomella L., Jameson B. A., Wernicke D., Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor 1. Cancer Res. 1993 Mar 1;53(5):1102–1106. [PubMed] [Google Scholar]
  23. Plowman G. D., Culouscou J. M., Whitney G. S., Green J. M., Carlton G. W., Foy L., Neubauer M. G., Shoyab M. Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1746–1750. doi: 10.1073/pnas.90.5.1746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Plowman G. D., Green J. M., McDonald V. L., Neubauer M. G., Disteche C. M., Todaro G. J., Shoyab M. The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumor-inhibitory activity. Mol Cell Biol. 1990 May;10(5):1969–1981. doi: 10.1128/mcb.10.5.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Salomon D. S., Kim N., Saeki T., Ciardiello F. Transforming growth factor-alpha: an oncodevelopmental growth factor. Cancer Cells. 1990 Dec;2(12):389–397. [PubMed] [Google Scholar]
  26. Sato J. D., Kawamoto T., Le A. D., Mendelsohn J., Polikoff J., Sato G. H. Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors. Mol Biol Med. 1983 Dec;1(5):511–529. [PubMed] [Google Scholar]
  27. Schuurmans A. L., Bolt J., Mulder E. Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP. Prostate. 1988;12(1):55–63. doi: 10.1002/pros.2990120108. [DOI] [PubMed] [Google Scholar]
  28. Shain S. A., Ke L. D., Wong G., Karaganis A. G. Rat prostate cancer cell line-specific production and apparent secretion of heparin-binding growth factors. Cell Growth Differ. 1992 Apr;3(4):249–258. [PubMed] [Google Scholar]
  29. Shoyab M., McDonald V. L., Bradley J. G., Todaro G. J. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6528–6532. doi: 10.1073/pnas.85.17.6528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G., Todaro G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science. 1989 Feb 24;243(4894 Pt 1):1074–1076. doi: 10.1126/science.2466334. [DOI] [PubMed] [Google Scholar]
  31. Sternfeld M. D., Hendrickson J. E., Keeble W. W., Rosenbaum J. T., Robertson J. E., Pittelkow M. R., Shipley G. D. Differential expression of mRNA coding for heparin-binding growth factor type 2 in human cells. J Cell Physiol. 1988 Aug;136(2):297–304. doi: 10.1002/jcp.1041360212. [DOI] [PubMed] [Google Scholar]
  32. Todaro G. J., Rose T. M., Spooner C. E., Shoyab M., Plowman G. D. Cellular and viral ligands that interact with the EGF receptor. Semin Cancer Biol. 1990 Aug;1(4):257–263. [PubMed] [Google Scholar]
  33. Wilding G., Valverius E., Knabbe C., Gelmann E. P. Role of transforming growth factor-alpha in human prostate cancer cell growth. Prostate. 1989;15(1):1–12. doi: 10.1002/pros.2990150102. [DOI] [PubMed] [Google Scholar]
  34. Zuck B., Goepfert C., Nedlin-Chittka A., Sohrt K., Voigt K. D., Knabbe C. Regulation of fibroblast growth factor-like protein(s) in the androgen-responsive human prostate carcinoma cell line LNCaP. J Steroid Biochem Mol Biol. 1992 Mar;41(3-8):659–663. doi: 10.1016/0960-0760(92)90400-d. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES